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hypoxia-inducible transcription factor prolyl-4-hydroxylase
PHD2 protein stability
Abstract
The heterodimeric hypoxia-inducible transcription factors (HIFs) are central regulators of the response
to low oxygenation. HIF-alpha subunits are constitutively expressed but rapidly degraded under
normoxic conditions. Oxygen-dependent hydroxylation of two conserved prolyl residues by
prolyl-4-hydroxylase domain-containing enzymes (PHDs) targets HIF-alpha for proteasomal
destruction. We identified the peptidyl prolyl cis/trans isomerase FK506-binding protein 38 (FKBP38)
as a novel interactor of PHD2. Yeast two-hybrid, glutathione S-transferase pull-down,
coimmunoprecipitation, colocalization, and mammalian two-hybrid studies confirmed specific FKBP38
interaction with PHD2, but not with PHD1 or PHD3. PHD2 and FKBP38 associated with their
N-terminal regions, which contain no known interaction motifs. Neither FKBP38 mRNA nor protein
levels were regulated under hypoxic conditions or after PHD inhibition, suggesting that FKBP38 is not a
HIF/PHD target. Stable RNA interference-mediated depletion of FKBP38 resulted in increased PHD
hydroxylation activity and decreased HIF protein levels and transcriptional activity. Reconstitution of
FKBP38 expression abolished these effects, which were independent of the peptidyl prolyl cis/trans
isomerase activity. Downregulation of FKBP38 did not affect PHD2 mRNA levels but prolonged PHD2
protein stability, suggesting that FKBP38 is involved in PHD2 protein regulation.
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The heterodimeric hypoxia-inducible transcription factors (HIFs) are central regulators of the response to
low oxygenation. HIF- subunits are constitutively expressed but rapidly degraded under normoxic conditions.
Oxygen-dependent hydroxylation of two conserved prolyl residues by prolyl-4-hydroxylase domain-containing
enzymes (PHDs) targets HIF- for proteasomal destruction. We identified the peptidyl prolyl cis/trans isomer-
ase FK506-binding protein 38 (FKBP38) as a novel interactor of PHD2. Yeast two-hybrid, glutathione S-
transferase pull-down, coimmunoprecipitation, colocalization, and mammalian two-hybrid studies confirmed
specific FKBP38 interaction with PHD2, but not with PHD1 or PHD3. PHD2 and FKBP38 associated with their
N-terminal regions, which contain no known interaction motifs. Neither FKBP38 mRNA nor protein levels were
regulated under hypoxic conditions or after PHD inhibition, suggesting that FKBP38 is not a HIF/PHD target.
Stable RNA interference-mediated depletion of FKBP38 resulted in increased PHD hydroxylation activity and
decreased HIF protein levels and transcriptional activity. Reconstitution of FKBP38 expression abolished
these effects, which were independent of the peptidyl prolyl cis/trans isomerase activity. Downregulation of
FKBP38 did not affect PHD2 mRNA levels but prolonged PHD2 protein stability, suggesting that FKBP38 is
involved in PHD2 protein regulation.
The response to reduced tissue oxygenation (hypoxia) is
characterized by alterations in gene expression, allowing the
organism to adapt to hypoxia on the systemic, local, and cel-
lular levels (46). A large number of these target genes are
regulated by hypoxia-inducible factor 1 (HIF-1) and HIF-2, the
master regulators of oxygen homeostasis in physiological, as
well as in pathophysiological, processes (3, 34, 37). HIFs are
members of the basic helix-loop-helix/Per-ARNT-Sim (bHLH/
PAS) transcription factor family and bind as an / het-
erodimer to cis-regulatory hypoxia response elements (HREs)
(47). Oxygen-dependent regulation is mediated by the HIF-
subunits and involves novel enzymatic posttranslational mod-
ification pathways that hydroxylate specific amino acids, de-
pending on the oxygen partial pressure (36). A novel family of
oxygen-, ferrous iron-, and 2-oxoglutarate-dependent prolyl-4-
hydroxylase domain-containing enzymes (PHD1, PHD2, and
PHD3) mediate the proteolytic regulation of HIF- subunits
(4, 9, 15). Under normoxic conditions, two conserved prolyl
residues within the oxygen-dependent degradation (ODD) do-
main of HIF- are hydroxylated and recognized by the von
Hippel-Lindau (pVHL) tumor suppressor protein via trans-4-
hydroxyprolyl binding (16, 17, 25). pVHL serves as a substrate
recognition unit of an E3 ligase complex, targeting HIF- for
degradation by the ubiquitin-proteasome pathway. Because
PHDs depend on molecular oxygen as a cosubstrate, hydroxy-
lation is reduced in hypoxia, leading to HIF- stabilization and
accumulation. Thus, PHDs can serve as cellular oxygen sensors
and provide a direct link between oxygen availability and HIF-
dependent transcriptional regulation. In addition to the regu-
lation of protein stability, hydroxylation of a specific asparag-
inyl residue within the C-terminal transactivation domain of
HIF- by factor inhibiting HIF (FIH) prevents interaction with
the CH1 domains of the p300/CBP transcriptional coactiva-
tors, thus reducing the transcriptional activity of HIF- (13, 21,
22). FIH belongs to the same family as the PHDs, but its Km
for oxygen is lower (14, 20), providing an elegant way of fine
tuning HIF- stabilization and target gene induction by the
current tissue oxygenation.
All three PHD proteins are able to hydroxylate HIF- in
vitro, but they differ in their expression patterns, as well as in
their subcellular localization, at least when overexpressed (1,
26). However, recent analysis of endogenous localization
showed expression of all three PHD enzymes predominantly in
the cytoplasm (39). PHD2 is ubiquitously expressed and has
been shown to be the main hydroxylase responsible for HIF-
modification in normoxia (2). The recent description of a fam-
ily with erythrocytosis caused by an inherited PHD2 proline
point mutation confirmed these data (32). Interestingly, PHD2
and PHD3 are HIF-dependently regulated, constituting a neg-
ative feedback mechanism, whereas PHD1 is not regulated by
hypoxia (27, 33). In accordance with the complex functions of
HIF in various hypoxic adaptation processes, the PHD pro-
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teins also seem to be subjected to multilayer regulatory mech-
anisms, including modification of enzyme activity by posttrans-
lational modifications and protein associations (15, 24). To
screen for novel PHD interactors, we applied yeast two-hybrid
methodology using PHD2 as bait and identified the peptidyl
prolyl cis/trans isomerase FK506-binding protein 38 (FKBP38)
as prey.
MATERIALS AND METHODS
Plasmids. Unless otherwise indicated, cloning work was carried out using
Gateway technology (Invitrogen, Basel, Switzerland). Entry vectors were gener-
ated by cloning PCR fragments into BamHI/EcoRV-digested (all restriction
enzymes were purchased from MBI Fermentas, Labforce, Nunningen, Switzer-
land) pENTR4 or pENTR/D-TOPO vectors. Full-length PHD1 to -3 (accession
numbers NM_053046, NM_022051, and NM_022073, respectively) were ampli-
fied by PCR from plasmids pcDNA3.1/PHD1 (29), pcDNA3.1/HA-PHD2 (15),
and pcDNA3.1/PHD3 (29). pENTR/PHD2-170-426 was obtained by digesting
pENTR/PHD2 with SmaI and NotI, Klenow fill-in, and religation. To obtain
pDONR/FKBP38, as well as pDONR/FKBP3898-257, the BP Clonase recom-
bination enzyme mixture (Invitrogen) was used to transfer the corresponding
inserts from yeast two-hybrid library vectors into pDONR221. DNA fragments
corresponding to amino acids (aa) 3 to 97, aa 99 to 412, and aa 256 to 412 of
FKBP38 (accession number AY278607) were amplified by PCR from plasmid
pDONR-FKBP38 and cloned into pENTR4. The DNA fragment corresponding
to the HIF-2ODD-domain (aa 404 to 569) was amplified by PCR from plasmid
pcDNA3/hEPAS and cloned into pENTR/D-TOPO. The inserts of all entry and
donor vectors were verified by DNA sequencing (Microsynth, Balgach, Switzer-
land).
To generate fusion protein expression vectors, entry or donor vectors were
recombined in vitro with destination vectors using LR Clonase recombination
enzyme mix (Invitrogen). To generate expression plasmids for yeast two-hybrid
analysis, the destination vectors pDEST32 (Gal4 DNA-binding domain [Gal4-
DBD]) and pDEST22 (Gal4 activation domain [Gal4-AD]) were used. The
mammalian Matchmaker vectors pM and pVP16 (Clontech, BD Biosciences,
Heidelberg, Germany) were converted to destination vectors by ligation of the
Gateway vector conversion cassette reading frame B (Invitrogen) into the EcoRI
sites (blunted with Klenow polymerase) of pM and pVP16 to generate pMDEST
and pVP16DEST, respectively. Expression vectors for the Gal4-DBD (pM) and
VP16AD fusion proteins were obtained after in vitro recombination with the
corresponding entry vectors. The mammalian one-hybrid plasmid pM-HIF-1-
370-429-VP16AD was generated by cloning a PCR fragment (using primers
5-GTCAGAATTCAGAAAATGACTCAGCTATTCACCAA-3 and 5-CGAT
GAATTCGGAATGGTACTTCCTCAAGTTGCT-3) into the EcoRI site of
pM-VP16AD. Plasmids pDEST15 and pDEST17 were used to generate vectors
for glutathione S-transferase (GST) and His6 fusion protein expression in bac-
teria or in rabbit reticulocyte lysates. The plasmid used to generate recombinant
GST–HIF-1-530-826 was described previously (6). pDEST20 was used to gen-
erate expression vectors for GST fusion proteins in the baculovirus/Sf9 insect cell
system (Invitrogen). pcDNA3.1/nV5-DEST and pcDNA3.1/c-myc-DEST were
used to express N-terminal V5- and c-myc-tagged proteins in mammalian cells,
respectively. pcDNA3.1/c-myc-DEST was obtained by ligating c-myc oligonucle-
otides (synthesized by Microsynth) into pcDNA3.1/nV5-DEST digested with
EcoRV and HindIII.
Yeast two-hybrid analysis. Yeast two-hybrid analyses were performed using
the ProQuest system according to the manufacturer’s instructions (Invitrogen).
Full-length PHD2 fused to the Gal4-DBD was expressed from pDEST32-PHD2
in Saccharomyces cerevisiae strain MaV203 (Invitrogen). To test for self-activity,
cotransformants of pDEST32/PHD2 and pExpAD502, encoding the Gal4-AD,
were examined on selection plates. A Gateway-compatible ProQuest human
brain cDNA library was screened on synthetic dropout medium containing 10
mM 3-amino-1,2,4-triazole (Sigma, Buchs, Switzerland). The pExpAD502 plas-
mids encoding putative PHD2-interacting proteins were isolated, retested for
interaction, and tested for self-activity. Inserts of confirmed interactors were
sequenced to ensure in-frame coding sequence with the Gal4-AD.
Cell culture and transient transfection. Human Hep3B hepatoma, HeLa cer-
vical carcinoma, and HEK293 embryonic kidney carcinoma cell lines were cul-
tured in high-glucose Dulbecco’s modified Eagle’s medium (DMEM) (Sigma) as
described previously (6). Transient transfections were performed with the poly-
ethylenimine (Polysciences, Warrington, PA) method (42).
In vitro transcription/translation (IVTT) and GST pull-down. IVTT reactions
were carried out as described by the manufacturer (Promega, Madison, WI)
using recombined DEST vectors in the presence of [35S]Met (Hartmann Ana-
lytic, Braunschweig, Germany). GST and GST fusion proteins were expressed in
Escherichia coli BL21-AI by induction with 0.025% arabinose for 4 h and affinity
purified using glutathione-Sepharose columns (GSTrap FF; GE Healthcare,
Du¨bendorf, Switzerland) by liquid chromatography (BioLogic DuoFlow; Bio-
Rad, Reinach, Switzerland). Purified GST-tagged proteins (10 g) were diluted
in bead binding buffer (50 mM potassium phosphate, pH 7.5, 150 mM KCl, 1 mM
MgCl2, 10% glycerol, 1% TX-100) and incubated with glutathione-Sepharose
beads. For pull-down experiments, 20 l rabbit reticulocyte IVTT reaction mix-
ture was incubated for 2 h at 4°C with bound GST fusion proteins in coimmuno-
precipitation (co-IP) buffer (50 mM Tris-HCl, pH 7.6, 2 mM EDTA, 100 mM
NaCl, 0.1% TX-100), washed five times with co-IP buffer, boiled in sample buffer
(40 mM Tris-HCl, pH 6.8, 1% sodium dodecyl sulfate [SDS], 50 mM -mercap-
toethanol) for 5 min, and separated by SDS-polyacrylamide gel electrophoresis
(PAGE). The gels were stained with Coomassie blue and dried, and radioactively
labeled proteins were detected by phosphorimaging (Molecular Imager FX;
Bio-Rad).
Immunoblotting. Combined cytoplasmic and nuclear extracts of cultured cells
were prepared using 0.4 M NaCl and 0.1% NP-40 in extraction buffer as de-
scribed previously (23). Nuclear extracts were prepared from isolated nuclei
using 0.4 M NaCl. Protein concentrations were determined by the Bradford
method using bovine serum albumin as a standard. Immunoblot analyses were
performed as previously described (23). The following antibodies were used:
mouse monoclonal antibody (MAb) anti-V5 (Invitrogen), MAb anti-c-myc
(Roche Diagnostics, Rotkreuz, Switzerland), MAb anti--actin (Sigma), MAb
anti-HIF-1 (Transduction Laboratories, BD Biosciences), rabbit polyclonal
anti-PHD2 antibody (Novus, Abcam, Cambridge, United Kingdom), rabbit poly-
clonal anti-FKBP38 antibody (7), and secondary polyclonal goat anti-mouse and
anti-rabbit antibodies coupled to horseradish peroxidase (Pierce, Perbio, Lau-
sanne, Switzerland). Chemiluminescence detection was performed using Super-
signal West Dura (Pierce), and signals were recorded with a charge-coupled
device camera (FluorChem8900; AlphaInnotech, Witec, Littau, Switzerland) or
by exposure to X-ray film (Fujifilm, Dielsdorf, Switzerland).
Co-IP. HEK293 cells were transiently cotransfected with pcDNA3.1/V5-
FKBP38 and pcDNA3.1/c-myc-PHD2 using the polyethylenimine method. After
24 h, 107 cells were lysed with 1 ml nondenaturing lysis buffer (50 mM Tris-HCl,
pH 7.4, 300 mM NaCl, 5 mM EDTA, 1% TX-100, complete protease inhibitors
[Roche]). The lysates (500 l) were precleared with protein A agarose beads
(Roche) before incubation with protein A agarose beads bound to monoclonal
mouse anti-V5 (2 g; Invitrogen), anti-c-myc (2 g; Roche), or nonspecific
purified mouse immunoglobulin G (IgG) (2 g; Sigma) overnight at 4°C. Anti-
body-protein complexes were washed four times with wash buffer (50 mM Tris-
HCl, pH 7.4, 300 mM NaCl, 5 mM EDTA, 0.1% TX-100) and once with
phosphate-buffered saline (PBS) and eluted with SDS-PAGE sample buffer.
Immunofluorescence microscopy. Cells were cultivated on microscope slides,
washed twice with ice-cold PBS, and fixed on ice for 30 min with 4% parafor-
maldehyde. The cells were then permeabilized with 0.1% saponin in PBS. En-
dogenous FKBP38 was detected with rabbit anti-FKBP38 antibodies, and trans-
fected hemagglutinin (HA)-PHD2 was detected with mouse anti-HA antibodies
(Sigma). Immune complexes were visualized with goat anti-rabbit antibody–
Alexa 488 or goat anti-mouse antibody–Alexa 568 (Molecular Probes, Invitro-
gen), respectively. Finally, nuclei were stained with DAPI (4,6-diamidino-2-
phenylindole) (Sigma) for 30 min. After extensive washings with PBS, the slides
were mounted and analyzed by confocal laser scanning microscopy (SP1; Leica
Microsystems, Switzerland).
Reporter gene and mammalian one- and two-hybrid assays. Cloning of the
HIF-dependent firefly luciferase reporter gene construct pH3SVL was described
previously (45). Cells were cotransfected with 500 ng pH3SVL and 20 ng pRL-
SV40 Renilla luciferase reporter vector (Promega) to control for differences in
transfection efficiency and exposed to normoxic or hypoxic conditions for 16 h.
Mammalian one- and two-hybrid analyses were performed using the mammalian
Matchmaker system (Clontech, BD Biosciences). HeLa cells were transiently
cotransfected with one-hybrid or DBD and AD fusion protein vectors, together
with the firefly luciferase reporter vector pGRE5xE1b and pRL-SV40. Lucifer-
ase reporter gene activity was determined using the dual-luciferase reporter
assay system according to the manufacturer’s instructions (Promega).
RNAi. For silencing FKBP38 by RNA interference (RNAi), a pair of 63-
nucleotide oligonucleotides (Microsynth) targeting the sequence 5-AAGAGU
GGCUGGACAUUCUGG-3 were inserted into pSilencer2.1-U6 hygro di-
gested with BamHI and HindIII (Ambion, Huntingdon, United Kingdom) and
transfected into HeLa and Hep3B cells by calcium phosphate coprecipitation. A
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pool of clones were selected in medium containing 200 g/ml hygromycin B
(Calbiochem, VWR International, Lucerne, Switzerland), and single clones were
subsequently isolated by limited dilution. The downregulation of FKBP38 ex-
pression by RNAi was analyzed by real-time reverse transcriptase (RT) PCR and
immunoblotting and compared to cells containing the control oligonucleotide
harboring the vector pSilencer2.1-U6 hygro.
Pulse-chase experiment. HeLa cells were starved in DMEM (without fetal calf
serum [FCS]) lacking Met and Cys for 1 h. The cells were then incubated in the
same medium supplemented with 10% FCS (dialyzed against PBS) and [35S]Met/
Cys mixture (0.1 mCi/ml; Hartman Analytics, Braunschweig, Germany) for 2 h.
After the cells were washed twice with PBS, they were chased with DMEM-10%
FCS containing cold Met/Cys (3 mM each). During the chase period, cells were
harvested at different time points, and radioactively labeled PHD2 was immu-
noprecipitated and visualized by phosphorimaging.
In vitro prolyl-4-hydroxylation assay. HeLa cells were pelleted and Dounce
homogenized in cell lysis buffer (100 mM Tris-Cl, pH 7.5, 1.5 mM MgCl2, 8.75%
glycerol, 0.01% Tween 20) supplemented with complete protease inhibitors. The
lysates were centrifuged for 30 min at 4°C and 20,000  g, and pVHL-elongin
B-elongin C (VBC) binding was determined as previously described (23, 30).
RNA extraction and real-time RT-PCR quantification. Cells were grown in
15-cm plates under normoxic or hypoxic conditions, and total RNA was extracted
as described previously (23). First-strand cDNA synthesis was performed with 3
g of RNA using Superscript III Moloney murine leukemia virus RT according
to the manufacturer’s instructions (Invitrogen). Subsequently, mRNA expression
levels were quantified with 2 l of diluted cDNA reaction mixture by real-time
PCR using a SybrGreen Q-PCR reagent kit (Sigma) in combination with the
MX3000P light cycler (Stratagene, Amsterdam, The Netherlands). Initial tem-
plate concentrations of each sample were calculated by comparison with serial
dilutions of a calibrated standard. To verify RNA integrity and equal input levels,
ribosomal protein L28 mRNA was determined, and the data were expressed as
ratios relative to L28 levels. Primers were as follows: hL28 forward, 5-GCAAT
TCCTTCCGCTACAAC-3; hL28 reverse, 5-TGTTCTTGCGGATCATGTGT-
3; hGLUT1 forward, 5-TCACTGTGCTCCTGGTTCTG-3; hGLUT1 reverse,
5-CCTGTGCTCCTGAGAGATCC-3; hCAIX forward, 5-GGGTGTCATCT
GGACTGTGTT-3; hCAIX reverse, 5-CTTCTGTGCTGCCTTCTCACT-3;
hFKBP38 forward, 5-ACATGACGTTCGAGGAGGAG-3; hFKBP38 reverse,
5-GTTGGAAGGTTCCAGCTTCA-3; hPHD1 forward, 5-CTGGGCAGCTA
TGTCATCAA-3; hPHD1 reverse, 5-AAATGAGCAACCGGTCAAAG-3;
hPHD2 forward, 5-GAAAGCCATGGTTGCTTGTT-3; hPHD2 reverse, 5-T
TGCCTTCTGGAAAAATTCG-3; hPHD3 forward, 5-ATCGACAGGCTGG
TCCTCTA-3; and hPHD3 reverse, 5-CTTGGCATCCCAATTCTTGT-3.
RESULTS
Identification of FKBP38 as a specific PHD2 interactor. To
identify novel PHD2-interacting proteins, human PHD2 ex-
pressed as a fusion protein with the Gal4-DBD was used as bait
in a yeast two-hybrid screen of a human brain cDNA library. A
total of 2  106 individual transformants were screened, and
several independent cDNA clones encoding FKBP38 were
identified based on their abilities to activate the three reporter
genes His, Ura, and LacZ (data not shown). In order to confirm
these data in a yeast-independent interaction assay, GST pull-
down experiments were performed. PHD1, -2, and -3 were
subjected to IVTT in the presence of radioactive [35S]Met,
incubated with bacterially expressed and purified GST-
FKBP38, and precipitated by glutathione-Sepharose. As con-
trols, GST–HIF-1-530-826 and GST–HIF-2-404-569 were
also expressed and purified as GST fusion proteins. GST alone
was used as a noninteraction control. Whereas HIF- frag-
ments containing the ODD domain interacted with all three
PHDs, FKBP38 showed specific association with PHD2 only
(Fig. 1A), confirming the previous findings in yeast (data not
FIG. 1. FKBP38 interacts specifically with PHD2. (A) IVTT 35S-labeled PHD1, PHD2, and PHD3 were incubated with GST–HIF-1-530-826,
GST–HIF-2-404-569, GST-FKBP38, or GST alone. Bound proteins were pulled down and visualized by phosphorimaging. (B and C) Total cell
extracts from HEK293 cells transiently transfected with V5-FKBP38 and c-myc–PHD2 were incubated with anti-V5 (B) or anti-c-myc (C) anti-
bodies or with isotype-matched control IgG. The antibodies and bound proteins were immunoprecipitated and analyzed by immunoblotting (WB).
Coimmunoprecipitated PHD2 and FKBP38 were detected by specific antibodies. IP, immunoprecipitate. (D) Indirect immunofluorescence of
FKBP38 and PHD2. HeLa cells were transfected with a plasmid encoding HA-PHD2 and stained with antibodies to FKBP38 (green) and HA
(red), followed by fluorescently labeled secondary antibodies.
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shown). The stronger binding of PHD2 to HIF-2-404-569
than to HIF-1-530-603 might be due to the presence of both
hydroxylated proline residues in the recombinant HIF-2 pro-
tein (P405 and P531) versus just the C-terminal proline in
HIF-1 (P564).
To confirm the FKBP38:PHD2 interaction in a mammalian
system, we transiently transfected HEK293 cells with V5-
tagged FKBP38 and c-myc-tagged PHD2. Tag-specific anti-
bodies were then used for co-IPs. V5-FKBP38 interacted with
exogenous, as well as with endogenous, PHD2 (Fig. 1B), and
c-myc–PHD2 was found in a complex with both overexpressed
and cellular FKBP38 (Fig. 1C). Nonspecific isotype-matched
mouse IgG served as an immunoprecipitation control.
We next investigated whether FKBP38 colocalizes with
PHD2 in HeLa cells. Since the antibodies directed against
these two proteins were generated in rabbits, we transiently
transfected HA-PHD2 and used mouse anti-HA antibodies to
detect PHD2. Immunofluorescence analysis indicated that en-
dogenous FKBP38 colocalized with HA-PHD2 in the cyto-
plasm of HeLa cells (Fig. 1D).
Mapping of the PHD2 interaction site in FKBP38. FKBP38
belongs to the enzyme class of peptidyl prolyl cis/trans isomer-
ases (PPIases), and the amino-terminal region of FKBP38 con-
tains a PPIase domain of the FKBP type, harboring PPIase-
and FK506-binding activities. In addition, FKBP38 contains
three tetratricopeptide repeats, a calmodulin-binding site, and
a membrane anchor in its carboxy-terminal half (7, 38). Based
on the predicted domain architecture of FKBP38 (Fig. 2A), a
series of deletion mutants fused to GST were designed, ex-
pressed in bacteria, purified, and analyzed for PHD2 interac-
tion in GST pull-down experiments. Radioactively labeled
PHD2 was produced by IVTT, and the interaction of labeled
PHD2 with purified GST-FKBP38 deletion constructs, or GST
alone, was tested. The N-terminal FKBP38 fragment contain-
ing aa 3 to 97 was sufficient to maintain interaction with PHD2
(Fig. 2B). The PPIase domain was not required for PHD2
interaction. On the other hand, an N-terminally truncated
PHD2 protein (PHD2 aa 170 to 426) interacted with GST–
HIF-2-404-569 but not with GST-FKBP38 (Fig. 2C). Similar
results were obtained in yeast two-hybrid experiments (data
not shown). These data suggest that aa 3 to 97 of FKBP38 are
required for interaction with aa 1 to 169 of PHD2. The cata-
lytic domain of purified PHD2 is sufficient for HIF-2 ODD
domain binding and hydroxylation of HIF-1-derived peptides
(data not shown), suggesting that FKBP38 is not a PHD2
hydroxylation substrate.
FKBP38-PHD2 interaction and FKBP38 gene expression
are independent of the oxygen concentration. To investigate
whether the FKBP38-PHD2 interaction is oxygen-dependent,
we expressed PHD1, PHD2, or PHD3 fused to the Gal4-DBD,
together with the VP16AD fused to FKBP38, in a mammalian
two-hybrid system in HeLa cells. The activity of a cotransfected
luciferase reporter gene construct containing five Gal4-DBD
sites is greatly enhanced when the AD and DBD fusion pro-
teins interact with each other. As shown in Fig. 3A, luciferase
expression was significantly higher when the DBD-PHD2 and
AD-FKBP38 fusion constructs were cotransfected than in
transfection of either construct alone or AD-FKBP38 in com-
bination with DBD-PHD1 or DBD-PHD3, confirming specific
FKBP38-PHD2 interaction in mammalian cells. Cotransfec-
tion of DBD-PHD2 with the AD construct fused to FKBP38
deletions confirmed the findings in yeast, as well as the in vitro
interaction results mentioned above (data not shown). DBD-
p53, together with AD-CP (polyomavirus coat protein), served
as a negative control. In contrast to the significantly increased
luciferase activity under hypoxic conditions following cotrans-
fection of DBD-PHD2 with AD–HIF-2-404-569 (HIF-
2ODD), luciferase expression remained unchanged following
cotransfection of DBD-PHD2 with AD-FKBP38 under hy-
poxic and normoxic conditions.
FIG. 2. Mapping of the FKBP38 and PHD2 interaction sites. (A) Schematic representation of the predicted FKBP38 domain architecture and
the FKBP38 constructs used. TPR, tetratricopeptide repeats; CaM, calmodulin-binding site; TM, transmembrane domain. (B) IVTT 35S-labeled PHD2
was allowed to interact with GST-FKBP38, GST–FKBP3898-257, GST–FKBP38-3-97, GST–FKBP38-99-412, GST–FKBP38-256-412, or GST alone;
the protein complexes were precipitated by glutathione-Sepharose, separated by SDS-PAGE, and visualized by phosphorimaging. (C) IVTT 35S-labeled
PHD2-170-426 was tested for interaction with GST-FKBP38, GST–HIF-2-404-569, or GST alone and analyzed as described above.
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We next determined mRNA levels in cultured HeLa cells
exposed to normoxic or hypoxic conditions by real-time RT-
PCR. The known oxygen-regulated HIF target genes PHD2,
PHD3, GLUT1, and CAIX, but not FKBP38, PHD1, or L28
control mRNA, were induced by hypoxia (Fig. 3B). FKBP38
protein levels were not regulated by inhibition of PHDs with
dimethyloxalylglycine or by hypoxia, whereas HIF-1, as
well as PHD2, protein expression was increased following
PHD inhibition or hypoxic exposure (Fig. 3C). In summary,
these data demonstrate an oxygen-independent interaction
of FKBP38 with PHD2, suggesting that FKBP38 is not a
PHD2 substrate but might rather act as a cofactor.
RNAi-mediated FKBP38 silencing increases PHD-depen-
dent HIF-1 hydroxylation. To investigate the functional
consequences of the FKBP38-PHD2 interaction with regard
to the regulation of PHD activity, FKBP38 mRNA was
downregulated by RNAi. HeLa and Hep3B cells were trans-
fected with a FKBP38-silencing construct or with a control
plasmid harboring nonspecific oligonucleotides. Pools of clones
were generated by hygromycin B selection, and single clones
were isolated by limited dilution. As shown in Fig. 4A and B,
respectively, FKBP38 RNAi expression resulted in de-
creased endogenous FKBP38 mRNA, as well as protein
levels, in HeLa cells. Similar data were obtained in Hep3B
cells (data not shown). The ability of cell lysates derived
from FKBP38 RNAi clones to hydroxylate HIF-1 was in-
vestigated in an in vitro prolyl-4-hydroxylation assay. PHD
hydroxylation activity was measured by binding of the VBC
complex to HIF-1-derived peptides. Decreased FKBP38
resulted in a concomitant significant increase in hydroxyla-
tion activity (Fig. 4C). Reconstitution of FKBP38 gene ex-
pression using transiently transfected expression vectors
normalized prolyl hydroxylation (Fig. 4D), whereas trans-
fection with a lacZ expression vector had no effect (data not
shown).
Expression of a functional mutant FKBP38PPIase (FKBP
3898-257) resulted in normalized prolyl hydroxylation compara-
ble to transfection with FKBP38 (data not shown).
FIG. 3. FKBP38-PHD2 interaction and FKBP38 gene expression are not regulated by oxygen. (A) HeLa cells were transiently transfected with
Gal4-DBD and VP16AD fusion protein vectors and Gal4 response element-driven firefly luciferase reporter, as well as a Renilla luciferase control
vector. Following transfection, the cells were incubated under normoxic (20% O2) or hypoxic (0.2% O2) conditions, and luciferase reporter gene
activities were determined 16 h later. Firefly/Renilla luciferase activity ratios were normalized to the normoxic negative control DBD-p53/AD-CP
cotransfection, which was arbitrarily defined as 1. Mean values plus standard errors of the mean are shown for three independent experiments
performed in triplicate. (B and C) HeLa cells were cultured under normoxic (20% O2) or hypoxic (0.2% O2) conditions or treated with the PHD
inhibitor dimethyloxalylglycine (DMOG) (2 mM). (B) Total RNA was extracted after 8 h of incubation, and mRNA levels of FKBP38, PHD1 to
-3, GLUT1, CAIX, and ribosomal protein L28 were quantified by real-time RT-PCR. The transcript levels of these genes were normalized to L28,
and hypoxic inductions were calculated (mean, n  2). (C) Cellular proteins were extracted and separated by SDS-PAGE, and endogenous
FKBP38, PHD2, HIF-1, and -actin levels were analyzed by immunoblotting.
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FKBP38 silencing reduces HIF-1-dependent reporter gene
activity. To further investigate whether increased hydroxyla-
tion activity due to FKBP38 depletion affects HIF-dependent
reporter gene expression, wild-type HeLa, as well as FKBP38,
small interfering RNA (siRNA) cell clones were transiently
cotransfected with pH3SVL, containing six HIF-binding sites
from the transferrin HRE and a Renilla luciferase control
plasmid. Luciferase activity was reduced under hypoxic condi-
tions in FKBP38-depleted cell clones compared with control
cells (Fig. 5A). It has recently been reported that PHD2 is
able to modulate HIF-1 transcriptional activity (44), and
therefore, we established a mammalian one-hybrid assay to
investigate HIF-1 protein stability directly. FKBP38
siRNA cell clones were transiently cotransfected with HIF-
1-370-429 fused at the N-terminal end with Gal4-DBD and
at the C-terminal end with VP16AD, a firefly luciferase
reporter gene construct containing five Gal4-DBDs, and a
Renilla luciferase control plasmid. As shown in Fig. 5B,
luciferase activity was significantly reduced under normoxic
as well as hypoxic conditions in FKBP38-depleted cell
clones compared with control cells. Reconstitution of V5-
FKBP38 with a FKBP38 expression vector, but not with a
lacZ control vector, rescued luciferase activity (Fig. 5C).
Overexpression of a functional FKBP38 mutant that does
not bind PHD2 (FKBP38-99-412) resulted in luciferase ac-
tivities comparable to the lacZ control transfections (Fig.
5C). The nonimmunosuppressive small molecule GPI1046
[3-(3-pyridyl)-1-propyl (2S)-1-(3,3-dimethyl-1,2-dioxopen-
tyl)-2-pyrrolidine carboxylate] mimics the FK506 residues
interacting with FKBP38. GPI1046 has been shown to pref-
erentially bind FKBP38 and to inhibit the PPIase activity
with a Ki of 48 nM (7, 40). Addition of GPI1046, to inhibit
FKBP38 PPIase activity, to V5-FKBP38 reconstituted cells
had no effect, indicating a PPIase-independent function of
FKBP38 in the regulation of HIF-1 hydroxylation (data not
shown). Note that relative luciferase activities were gener-
ally higher in functional FKBP38 reconstituted clones than
in cells transfected with FKBP38, mutant for PHD2 binding,
or lacZ, suggesting that overexpression of FKBP38 reduces
PHD-dependent degradation of the HIF one-hybrid con-
struct.
Reduced FKBP38 gene expression leads to increased PHD2
protein levels and attenuates HIF-dependent gene expression.
The enhanced hydroxylation and reduced HIF-1-dependent
one-hybrid reporter gene activity found in FKBP38-depleted
cells could be based on modification of the enzymatic activity
itself and/or on elevated enzyme abundance. However, incu-
bation of active GST-PHD2 fusion protein purified from bac-
ulovirus-infected Sf9 cells with recombinant GST-FKBP38 did
not influence PHD2 hydroxylation activity as measured by the
FIG. 4. Enhanced hydroxylation activity by RNAi-mediated FKBP38 depletion. HeLa cells were transfected with vectors containing FKBP38
RNAi or control oligonucleotides, and stable clones were selected (3A5, 3D6, and 2G8). (A) Total RNA was extracted, and FKBP38 transcript
levels were determined by real-time RT-PCR and normalized to L28 mRNA levels (mean, n  2). (B) Total cell extracts were prepared and
analyzed by immunoblotting for FKBP38 and -actin expression. Total cell extracts of untransfected (C) and FKBP38-reconstituted (D) stable
RNAi clones were prepared, and hydroxylation activity was measured using the VBC-binding assay. Shown are mean values of relative VBC
binding plus standard errors of the mean of three independent experiments performed in triplicate. P values were obtained by paired t tests (*,
P 	 0.05). Subsequently, cell extracts were analyzed by immunoblotting for endogenous FKBP38, transfected V5-FKBP38, and -actin expression.
wt, wild type; ctrl, control.
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VBC capture assay (data not shown). Therefore, we analyzed
PHD2 protein levels in FKBP38 RNAi cell clones and ob-
served enhanced PHD2 levels inversely related to FKBP38
(Fig. 6A, left). Transient transfection of these FKBP38 RNAi
cells with V5-FKBP38 restored the low constitutive PHD2 pro-
tein levels, comparable to those of wild-type HeLa cells (Fig. 6A,
middle). Addition of GPI1046 did not influence PHD2 protein
levels in wild-type HeLa or FKBP38 RNAi cell clones, again
indicating a PPIase-independent effect (Fig. 6A, right). The same
results were obtained by treating cells with N-(N,N-dimethylcar-
boxamidomethyl)-cycloheximide, another FKBP38 PPIase inhib-
itor (reference 8 and data not shown).
PHD1, PHD2, and PHD3 mRNA levels were not affected by
downregulation of FKBP38, indicating that PHD2 is posttran-
scriptionally regulated by FKBP38 (Fig. 6B). To analyze
whether FKBP38 is able to attenuate endogenous HIF-1 pro-
tein expression by modification of PHD2 abundance, HeLa
control cells and FKBP38 RNAi cell clones were cultured
under hypoxic conditions and analyzed by immunoblotting.
PHD2 protein levels were inversely related to FKBP38 expres-
sion even under hypoxic conditions (Fig. 6C). Note that ele-
vated PHD2 protein levels in FKBP38-silenced cells compared
to control cells are less pronounced, because hypoxia upregu-
lated PHD2 expression in the control cells. HIF-1 protein was
not detectable under normoxic conditions but strongly in-
creased in hypoxic control cells. Strikingly, HIF-1 protein
levels markedly decreased in hypoxic FKBP38-depleted cells,
suggesting that elevated PHD2 levels lead to increased proteo-
lytic destruction of HIF-1, even under hypoxic conditions
(Fig. 6C).
Reduced HIF-1 protein levels might explain the less pro-
nounced increase in PHD2 levels under hypoxic conditions.
Indeed, hypoxia-inducible transcripts of HIF target genes, in-
cluding PHD2, PHD3, and GLUT-1 but not PHD1, were at-
tenuated two- to threefold in FKBP38 knockdown cell clones
(Fig. 6D). These results indicate that increased PHD2 abun-
dance in FKBP38 RNAi cell clones led to elevated HIF-
substrate hydroxylation and subsequent degradation, finally
resulting in decreased HIF function in the cell.
PHD2 protein stability is increased in FKBP38-downregu-
lated cells. Increased PHD2 protein levels in FKBP38-de-
pleted cells could be due to increased translation or protein
stability. To analyze PHD2 protein stability, we performed
pulse-chase experiments in wild-type HeLa and FKBP38-si-
lenced HeLa 2G8 cells (Fig. 7A). Whereas the measured half-
life of PHD2 was about 20 h in wild-type cells, it was ex-
trapolated to approximately twice as long when FKBP38 was
downregulated. In addition, cycloheximide treatment and
subsequent analysis of PHD2 protein levels showed a half-
FIG. 5. FKBP38 regulates HIF-dependent reporter gene activity.
(A) HeLa wild-type (wt) as well as FKBP38 siRNA cell clones were
cotransfected with pH3SVL and pRL-SV40 Renilla luciferase reporter
vectors and cultivated for 16 h under normoxic (20% O2) or hypoxic
(0.2% O2) conditions before relative luciferase activities were deter-
mined. The results are mean values plus standard errors of the mean
of five independent experiments performed in triplicate. ctrl, control.
(B) Stable FKBP38 RNAi HeLa clones were transiently transfected
with Gal4-DBD–HIF-1-370-429–VP16AD expression vectors (sche-
matically represented) and Gal4 response element-driven firefly lucif-
erase reporter, as well as a Renilla luciferase control vector. (C) HeLa
clones were cotransfected with the one-hybrid reporter gene vectors
and FKBP38, FKBP38-99-412, or lacZ control expression vectors.
Eight hours posttransfection, the cells were cultured under either nor-
moxic or hypoxic conditions for an additional 16 h, and firefly lucifer-
ase activities were determined and corrected for Renilla luciferase
activity. The results are mean values of relative luciferase activities plus
standard errors of the mean of at least three independent experiments
performed in triplicate. P values were obtained by paired t tests (**,
P	 0.01; *, P	 0.05). Expression of the transfected V5-tagged vectors
was verified by immunoblotting against V5 and -actin.
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life in the same range, as determined by pulse-chase in
control HeLa cells, whereas PHD2 protein stability was
markedly elevated in FKBP38-downregulated cell clones
(Fig. 7B). These experiments suggest a function of FKBP38
in the proteolytic regulation of PHD2. FKBP38 protein lev-
els remained constant for up to 32 h during cycloheximide
treatment (Fig. 7C). PHD2 is induced in HeLa cells by
incubation under hypoxic conditions for 24 h. After reoxy-
genation, PHD2 levels remain increased for up to 24 h and
afterwards slowly decline. In contrast, in FKBP38-down-
regulated HeLa cells, PHD2 remained elevated even after
72 h of reoxygenation (Fig. 7D), indicating that FKBP38 is
FIG. 6. Increased PHD2 protein stability in FKBP38-depleted cells. (A) Wild-type HeLa cells (wt), stable FKBP38-silenced HeLa clones,
V5-FKBP38 reconstituted HeLa cells, or FKBP38-silenced HeLa cells treated with the FKBP38 inhibitor GPI1046 (10 M) were cultivated under
normoxic (20% O2) conditions, and FKBP38, V5-FKBP38, PHD2, or -actin was detected by immunoblotting. (B) Total RNA was extracted and
reverse transcribed into cDNA, and mRNA levels of PHD1, PHD2, and PHD3 were normalized to ribosomal L28 mRNA levels as quantified by
real-time RT-PCR (n  2). ctrl, control. (C) Total hypoxic FKBP38 RNAi cell clone lysates were separated by SDS-PAGE and analyzed for
FKBP38, PHD2, HIF-1, and -actin protein levels by immunoblotting. (D) Total RNA was extracted after 8 h of incubation in normoxia or
hypoxia, and mRNA levels of FKBP38, PHD1 to -3, GLUT1, and ribosomal L28 were quantified by real-time RT-PCR. The transcript levels of
these genes were normalized to L28 mRNA, and hypoxic inductions were calculated (n  2).
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also required for the regulation of PHD2 protein levels
under reoxygenation conditions.
DISCUSSION
Although oxygen-dependent hydroxylation directly links ox-
ygen availability to HIF- protein stabilization and transcrip-
tional activity, both HIF and PHD hydroxylase activities are
likely to be subjected to additional levels of regulation. Indeed,
a HIF-dependent regulatory feedback mechanism has been
shown to increase PHD2 and PHD3 protein abundance under
hypoxic conditions, suggesting a role during reoxygenation (9).
We recently found that inducible PHD2 and PHD3 mRNA
levels remain upregulated under prolonged hypoxic exposure
and that PHDs maintain a functional HIF- hydroxylation
activity even under severe hypoxic conditions (42). Biochemi-
cal analysis of a PHD2 protein complex, consisting of approx-
imately 15 proteins with an apparent molecular mass of 320 to
440 kDa, indicated that PHD2 might be part of a large het-
eromeric complex (15). The formation of stable complexes
with other proteins raises the possibility that such proteins
might be involved in the regulation of PHD2 function, e.g.,
through chaperones; modulation of access to the cosubstrates
oxygen, ferrous iron, 2-oxoglutarate, and probably ascorbate;
and target protein recognition. Because HIF prolyl hydroxyla-
tion is a nonreversible process, differences in PHD protein
abundance would also be a means of regulating hydroxylation
activity.
We identified FKBP38 as a PHD2-associated nonsubstrate
protein and showed that silencing of FKBP38 results in in-
creased PHD2 stability, leading to enhanced hydroxylation and
attenuated HIF-dependent transcription. Conversely, FKBP38
overexpression resulted in elevated HIF reporter gene activity
in transient transfections (data not shown), as well as in one-
hybrid assays (Fig. 5C). Whereas PHD1 and PHD3 are tar-
geted for proteasomal degradation by the E3 ubiquitin ligases
Siah1a and Siah2 under hypoxic conditions, it is so far un-
known how PHD2 is posttranslationally regulated (28). Al-
though the molecular mechanism remains elusive, FKBP38-
dependent decreased PHD2 protein stability provides the first
data concerning the proteolytic regulation of PHD2 and at-
tributes a novel function to FKBP38.
The enzyme class of PPIases encompasses the immunophilin
families of cyclophilins and FKBPs, which were originally dis-
covered as cellular receptors of the immunosuppressive drugs
cyclosporine A and FK506, respectively (11, 43). Although
structurally unrelated, the two subfamilies share the common
enzymatic activity to catalyze the isomerization of the cis and
trans conformers of peptide bonds preceding prolines (10).
The singularity of peptidyl-prolyl bonds in peptide chains is
caused by the formation of an imidic peptide bond at the N
FIG. 7. Increased PHD2 protein stability in FKBP38-silenced cells. (A) The half-lives of PHD2 protein in wild-type HeLa (wt) and FKBP38-
depleted (2G8) cells were monitored by a pulse-chase experiment. Cells were metabolically labeled with [35S]Met/Cys for 2 h, followed by chase
for the indicated times. PHD2 was immunoprecipitated from the cell lysates with anti-PHD2 antibodies, and signals were detected by autora-
diography. Translation was blocked in FKBP38 RNAi HeLa clones by addition of 100 M cycloheximide and PHD2 (B), as well as FKBP38
(C), and protein levels were determined after the indicated time periods by immunoblotting. Subsequent detection of -actin served as a
loading control. (D) Total lysates of HeLa cells were prepared at the indicated periods of hypoxia or hypoxia followed by reoxygenation, and
PHD2 as well as -actin levels were detected by immunoblotting.
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terminus of the N-alkylated amino acid proline that is unique
among amino acids. The rate of the uncatalyzed interconver-
sion between the prolyl cis/trans isomers is low, pointing to an
involvement of PPIases in protein folding. It has been shown
for collagen that proline hydroxylation occurs on the nascent
polypeptide chain during translation, and subsequent cyclophi-
lin-assisted cis/trans isomerization is the rate-limiting step for
collagen helix formation. Procollagen folding is slowed down
by the addition of cyclosporine A (41).
Because VHL binds to HIF- trans-4-hydroxyprolyl residues
(16, 17), we speculated that the PPIase FKBP38 might act as a
PHD2 cofactor, influencing the conformation of HIF- prolyl
residues and/or the activity of PHD2. However, FKBP38 did
not physically interact with HIF- in yeast or mammalian two-
hybrid assays (data not shown), suggesting that FKBP38 does
not influence the conformation of the HIF- ODD domain.
On the other hand, the PPIase domain of FKBP38 was not
required for PHD2 interaction (Fig. 2), Ca2/calmodulin-me-
diated activation of recombinant FKBP38 did not modulate
the hydroxylation capacity of PHD2 (data not shown), and the
small-molecule FKBP38 PPIase inhibitor GPI1046, as well as
N-(N,N-dimethylcarboxamidomethyl)-cycloheximide, did not
influence PHD2 protein abundance (Fig. 6A and data not
shown, respectively). These data provide evidence that the
effect of FKBP38 on PHD2 abundance is PPIase independent.
FKBP38 is widely expressed in both adult and embryonic
tissues, as well as in different cancer cell lines (5, 18). Recently,
knockout mice showed that FKBP38 plays an essential role
during development. FKBP38 acts as a negative regulator of
the sonic hedgehog (SHH) pathway, and its loss leads to ec-
topic and ligand-independent activation of SHH signaling, re-
sulting in disturbed cell fate determination and embryonic
lethality (5). However, the molecular function of FKBP38 in
the SHH pathway remains elusive, and it will be interesting to
determine whether PHD2 is involved.
An interaction of FKBP38 with Bcl-2 has also been de-
scribed (38), but the functional consequences of this associa-
tion remain controversial. Antiapoptotic (38), as well as pro-
apoptotic (7), effects have been reported, probably depending
on the cellular context. The two proteins interacted only upon
Ca2 influx and subsequent FKBP38 activation. However, we
did not observe a cofactor-dependent interaction of FKBP38
with PHD2, nor did the addition of Ca2 to cell lysates alter
the hydroxylation activity, and cell viability was not affected
by RNAi-mediated downregulation of FKBP38 as measured
by MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium
bromide] assays (data not shown). Further potential functions
of FKBP38 include antitumor effects by regulation of anti-
invasive syndecan 1 and suppression of proinvasive MMP9 and
regulation of cell size via the tuberous sclerosis complex (12,
35). Clearly, the increasing amount of data about potential
FKBP38 functions suggests that FKBP38 is a multifunctional
protein involved in the regulation of many cellular processes,
but further studies are required for a better comprehension of
the biochemical functions of FKBP38.
In addition to FKBP38, the candidate tumor suppressor
ING4 was shown to associate with PHD2, suppressing HIF
activity and thereby possibly attenuating HIF target genes in-
volved in tumor growth and angiogenesis (31). It has been
proposed that ING4 retains PHD2 in the nucleus in order to
degrade HIF upon reoxygenation. However, recent data
showed predominant cytoplasmic localization of PHD2 (39).
PHD2 has a calculated molecular mass of 46 kDa, enabling it
to pass through nuclear pores, and it might be actively ex-
cluded from the nucleus by interaction with FKBP38. FKBP38
contains a C-terminal transmembrane domain that anchors the
protein in the mitochondrial and endoplasmic reticulum mem-
branes, and our immunofluorescence data also show a patchy
cytoplasmic staining for PHD2, indicating an association with
subcellular cytoplasmic structures (Fig. 1D). Additionally, it
has recently been demonstrated that PHD2 interacts with the
HIF-1 C-terminal ODD domain (aa 498 to 603) and thereby
reduces the transcriptional activity of this fragment (44). Al-
though we cannot exclude the possibility that attenuation of
HIF-1 transcriptional activity by PHD2 is involved in reduced
hypoxic HIF-dependent reporter gene (Fig. 5A) as well as HIF
target gene (Fig. 6D) induction in FKBP38 siRNA clones, our
data suggest that elevated PHD2 protein levels attenuate hy-
poxic HIF-1 stabilization (Fig. 5B and 6C).
PHDs represent attractive new therapeutic targets to mod-
ulate HIF activity, and thus functional understanding of PHD
function and regulation is crucial. Recently, it has been re-
ported that an inherited mutation in the active site of PHD2
leads to decreased hydroxylation activity and is associated with
familial erythrocytosis (32). These data confirm previous stud-
ies with cultured cells implicating PHD2 as the primary PHD
isoform responsible for HIF regulation under physiological
conditions (2). Interestingly, a screen for genetic mutations in
endometrial cancer cells identified PHD2 as being mutated at
significantly higher frequencies (19). Expression of wild-type
PHD2 in mutated cells induced senescence by negatively reg-
ulating HIF-1 expression, suggesting that PHD2 might be a
candidate tumor suppressor. Specific upregulation of PHD2 in
a FKBP38-dependent manner opens novel possibilities for in-
terfering with one PHD family member specifically, thereby
attenuating HIF signaling in cancer cells.
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